139 related articles for article (PubMed ID: 16650445)
21. Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters.
Baumbusch LO; Myhre S; Langerød A; Bergamaschi A; Geisler SB; Lønning PE; Deppert W; Dornreiter I; Børresen-Dale AL
Mol Cancer; 2006 Oct; 5():47. PubMed ID: 17054774
[TBL] [Abstract][Full Text] [Related]
22. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
[TBL] [Abstract][Full Text] [Related]
23. Polymorphisms in DNA repair genes XPD and XRCC1 and p53 mutations in lung carcinomas of never-smokers.
Gao WM; Romkes M; Siegfried JM; Luketich JD; Keohavong P
Mol Carcinog; 2006 Nov; 45(11):828-32. PubMed ID: 16865671
[TBL] [Abstract][Full Text] [Related]
24. Evolutionary conservation and mutational spectrum of BMPR2 gene.
Wong WK; Morse JH; Knowles JA
Gene; 2006 Mar; 368():84-93. PubMed ID: 16361068
[TBL] [Abstract][Full Text] [Related]
25. [Phylogenetic analysis of the family of p53].
Pintus SS; Fomin ES; Ivanisenko VA; Kolchanov NA
Biofizika; 2006; 51(4):640-9. PubMed ID: 16909841
[TBL] [Abstract][Full Text] [Related]
26. A phylogenetic approach to assessing the significance of missense mutations in disease genes.
Santibáñez Koref MF; Gangeswaran R; Santibáñez Koref IP; Shanahan N; Hancock JM
Hum Mutat; 2003 Jul; 22(1):51-8. PubMed ID: 12815593
[TBL] [Abstract][Full Text] [Related]
27. In silico p53 mutation hotspots in lung cancer.
Lewis PD; Parry JM
Carcinogenesis; 2004 Jul; 25(7):1099-107. PubMed ID: 14729588
[TBL] [Abstract][Full Text] [Related]
28. Strength of the purifying selection against different categories of the point mutations in the coding regions of the human genome.
Gorlov IP; Kimmel M; Amos CI
Hum Mol Genet; 2006 Apr; 15(7):1143-50. PubMed ID: 16500998
[TBL] [Abstract][Full Text] [Related]
29. Identification of four new PITX2 gene mutations in patients with Axenfeld-Rieger syndrome.
Vieira V; David G; Roche O; de la Houssaye G; Boutboul S; Arbogast L; Kobetz A; Orssaud C; Camand O; Schorderet DF; Munier F; Rossi A; Delezoide AL; Marsac C; Ricquier D; Dufier JL; Menasche M; Abitbol M
Mol Vis; 2006 Dec; 12():1448-60. PubMed ID: 17167399
[TBL] [Abstract][Full Text] [Related]
30. A putative exonic splicing enhancer in exon 7 of the PDHA1 gene affects splicing of adjacent exons.
Ridout CK; Keighley P; Krywawych S; Brown RM; Brown GK
Hum Mutat; 2008 Mar; 29(3):451. PubMed ID: 18273899
[TBL] [Abstract][Full Text] [Related]
31. Silent mutations in sight: co-variations in tRNA abundance as a key to unravel consequences of silent mutations.
Czech A; Fedyunin I; Zhang G; Ignatova Z
Mol Biosyst; 2010 Oct; 6(10):1767-72. PubMed ID: 20617253
[TBL] [Abstract][Full Text] [Related]
32. [Prediction of the possible tertiary structure alterations of p53 protein following point mutation in p53 gene condon 282 in lung cancer cells].
Du CH; Xu J; Zhong NS
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct; 26(10):1458-9. PubMed ID: 17062352
[TBL] [Abstract][Full Text] [Related]
33. N34S mutation in the SPINK1 gene is not associated with alternative splicing.
Masamune A; Kume K; Takagi Y; Kikuta K; Satoh K; Satoh A; Shimosegawa T
Pancreas; 2007 May; 34(4):423-8. PubMed ID: 17446841
[TBL] [Abstract][Full Text] [Related]
34. EGFR somatic doublets in lung cancer are frequent and generally arise from a pair of driver mutations uncommonly seen as singlet mutations: one-third of doublets occur at five pairs of amino acids.
Chen Z; Feng J; Saldivar JS; Gu D; Bockholt A; Sommer SS
Oncogene; 2008 Jul; 27(31):4336-43. PubMed ID: 18372921
[TBL] [Abstract][Full Text] [Related]
35. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional expression of cis-acting and trans-acting splicing mutations cause autosomal dominant retinitis pigmentosa.
Gamundi MJ; Hernan I; Muntanyola M; Maseras M; López-Romero P; Alvarez R; Dopazo A; Borrego S; Carballo M
Hum Mutat; 2008 Jun; 29(6):869-78. PubMed ID: 18412284
[TBL] [Abstract][Full Text] [Related]
37. Inferring the functional effects of mutation through clusters of mutations in homologous proteins.
Yue P; Forrest WF; Kaminker JS; Lohr S; Zhang Z; Cavet G
Hum Mutat; 2010 Mar; 31(3):264-71. PubMed ID: 20052764
[TBL] [Abstract][Full Text] [Related]
38. Missense mutations of BRCA1 gene affect the binding with p53 both in vitro and in vivo.
Quaresima B; Faniello MC; Baudi F; Crugliano T; Di Sanzo M; Cuda G; Costanzo F; Venuta S
Oncol Rep; 2006 Oct; 16(4):811-5. PubMed ID: 16969499
[TBL] [Abstract][Full Text] [Related]
39. P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations.
Mahdavinia M; Bishehsari F; Verginelli F; Cumashi A; Lattanzio R; Sotoudeh M; Ansari R; Semeraro D; Hormazdi M; Fakheri H; Rakhshani N; De Lellis L; Curia MC; Cama A; Piantelli M; Malekzadeh R; Iacobelli S; Mariani-Costantini R
J Cell Physiol; 2008 Aug; 216(2):543-50. PubMed ID: 18330889
[TBL] [Abstract][Full Text] [Related]
40. Analysis of mutational spectra: locating hotspots and clusters of mutations using recursive segmentation.
Fijal BA; Idury RM; Witte JS
Stat Med; 2002 Jul; 21(13):1867-85. PubMed ID: 12111894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
